Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cerilliant
Fuji
Argus Health
McKesson
Medtronic
Baxter
Queensland Health
US Department of Justice

Generated: May 22, 2018

DrugPatentWatch Database Preview

LARGON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Largon patents expire, and what generic alternatives are available?

Largon is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in LARGON is propiomazine hydrochloride. Additional details are available on the propiomazine hydrochloride profile page.
Summary for LARGON
Drug patent expirations by year for LARGON
Synonyms for LARGON
1-(10-(2-(Dimethylamino)propyl)phenothiazin-2-yl)-1-propanone
1-(10-(2-(Dimethylamino)propyl)phenothiazin-2-yl)-1-propanone monohydrochloride
1-[10-[2-(Dimethylamino)propyl]-10H-phenothiazin-2-yl]-1-propanone
1-[10-[2-(Dimethylamino)propyl]phenothiazin-2-yl-1-propanone
1-[10-[2-(Dimethylamino)propyl]phenothiazin-2-yl]-1-propanone
1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one
1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one hydrochloride
1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}-1-propanone
1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}propan-1-one
1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}propan-1-one hydrochloride
1-Propanone, 1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-
1-Propanone, 1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-, monohydrochloride
1-Propanone, 1-(10-(2-(dimethylamino)propyl)phenothiazin-2-yl)-
1-Propanone, 1-[10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl]-
1-Propanone, 1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]-
10-(2-Dimethylaminopropyl)-2-propionylphenothiazine
10-Dimethylaminoisopropyl-2-propionylphenothiazine
1240-15-9
2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine
2-Propionyl-10-[2-(dimethylamino)propyl]phenothiazine
3-Propionyl-10-dimethylaminoisopropylphenothiazine
362-29-8
AC1L1J9S
AC1L2GTP
AC1Q3DX3
BRD-A10471441-050-02-8
BSPBio_002237
C07384
C07405
CB-1678
CHEBI:8491
CHEBI:8492
CHEMBL1201068
CHEMBL1201210
D02361
D0R9ZB
DB00777
DivK1c_000296
Dorevan
Dorevan (TN)
Dorevane (TN)
DTXSID1023520
DTXSID80872383
EINECS 206-646-1
GTPL7284
HSDB 3275
HYDROGEN 1-{10-[2-(DIMETHYLAMINO)PROPYL]-10H-PHENOTHIAZIN-2-YL}PROPAN-1-ONE CHLORIDE
IDI1_000296
Indorm (TN)
KBio1_000296
KBio2_001352
KBio2_003920
KBio2_006488
KBio3_001737
KBioGR_001001
KBioSS_001352
L000807
Largon (TN)
LS-122934
LS-172585
NCGC00178744-01
NINDS_000296
Oprea1_617420
Phenoctyl
PL006599
PL043501
PL055095
Propavan (TN)
Propiomazin
Propiomazina
Propiomazina [INN-Spanish]
propiomazine
propiomazine hydrochloride
Propiomazine (USAN/INN)
Propiomazine [USAN:BAN:INN]
Propiomazine [USAN:INN:BAN]
Propiomazine HCl
Propiomazine hydrochloride
Propiomazine hydrochloride [USP]
Propiomazinhydrochlorid
Propiomazinum
Propiomazinum [INN-Latin]
Propionylpromethazine
s111
SCHEMBL141677
SCHEMBL93770
Serentin (TN)
SPBio_000840
Spectrum_000872
Spectrum2_000930
Spectrum3_000559
Spectrum4_000491
Spectrum5_001104
SureCN720224
UVOIBTBFPOZKGP-UHFFFAOYSA-N
Wy-1359

US Patents and Regulatory Information for LARGON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int LARGON propiomazine hydrochloride INJECTABLE;INJECTION 012382-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
AstraZeneca
Queensland Health
Chinese Patent Office
Citi
Federal Trade Commission
Mallinckrodt
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.